HHSN261201500003I; HHSN26100069; 400.012.0069.0001; NCI CCG; Appropriated; Master Trial in Lymphoma (MasterLymph), Moonshot; 09/28/2018-09/27/2023
$1,378,995N01FY2018CANIH
Leidos Biomedical Research, Inc., Frederick MD
Investigators
Abstract
HHSN261201500003I; HHSN26100069; 400.012.0069.0001; NCI CCG; Appropriated; Master Trial in Lymphoma (MasterLymph), Moonshot; 09/28/2018-09/27/2023
View original record on NIH RePORTER →